← Eichor
Study identifier: NCT07546292 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Enhancing Letter-Speech Sound Learning and Reading Network Activation With Transcranial Electrical Stimulation

Condition: Dyslexia, Developmental · Reading · Dyslexia  ·  Sponsor: Silvia Brem

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to 35 Years
Healthy volunteersYes

About this study

This study investigates the effects of transcranial electrical stimulation (tES) on the brain and its potential to enhance reading-related learning. Adult participants with a range of reading abilities will receive transcranial random noise stimulation (tRNS) while they perform an artificial orthography learning task. This task simulates letter-speech sound learning, an important first step during reading acquisition known to be impaired in individuals with developmental dyslexia. The effects of the intervention will be assessed using both behavioral measures and functional magnetic resonance imaging (fMRI).

This description comes directly from the study's public registry record.

Talk to the study team

Silvia Brem, Prof. Dr.  ·  +41 (0)58 384 67 11  ·  silvia.brem@kjpd.uzh.ch

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospital of PsychiatryZurich, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07546292